DOSE OF REALITY: REPORT FINDS BIG PHARMA CONTINUES TO SET OUT-OF-CONTROL LAUNCH PRICES ON NEW MEDICINES COMING TO MARKET
Reuters Analysis Finds Average Launch Price For Drugs Approved By FDA in 2025 Above…
CSRxP advocates for bipartisan solutions that hold pharmaceutical companies accountable for egregious pricing and anti-competitive practices that are the root cause of out-of-control drug prices in America.
We believe in market-based reforms to lower drug prices for patients through increased transparency, competition and value.
Big Pharma’s business-as-usual playbook relies on egregious pricing practices and rhetoric designed to set and keep drug prices high.
Drug prices in the United States are out of control as a direct result of the egregious pricing and anti-competitive practices of brand name pharmaceutical companies. Rising prescription drug prices threaten the affordability of our health care system, the long-term health of our nation and the vitality of our entire economy. Public opinion research finds as many as one-in-three Americans experience financial difficulty, either as a patient themselves or through a family member, affording prescription drugs. CSRxP has developed market-based solutions to restore a functioning market and lower prices for patients by increasing list price transparency, promoting competition and actual innovation and focusing on better value for patients, not better value for pharmaceutical companies.
Reuters Analysis Finds Average Launch Price For Drugs Approved By FDA in 2025 Above…
Lawmakers Advance Bipartisan Solutions to Hold Big Pharma Accountable for…
Committee Markup Advances Solutions to Crack Down on Big Pharma’s Patent Abuse and…
Big Pharma’s Arguments Against Bipartisan, Market-Based Solutions to Foster Greater…

Several bipartisan, market-based solutions that would help foster greater… Read More
How Congress Can Lower Drug Prices, Boost Competition Trio of Bipartisan… Read More
Brand name drug manufacturers game the patent system and drug approval process… Read More
Two bipartisan solutions — the ETHIC Act and Skinny Labels… Read More
Watch and learn about Big Pharma’s price-gouging techniques that are the cause of out-of-control drug prices.
Get the facts on Big Pharma’s anti-competitive tactics, like price-gouging and patent abuse that keeps drug prices high.
Learn about how Big Pharma is driving the Rx drug pricing crisis with our infographics.
See recent surveys on American voters’ opinions on Big Pharma’s blame game and out-of-control drug pricing.
Join us in telling lawmakers: It’s time to hold Big Pharma accountable and lower Rx drug prices.